DWP-450 (Botulinum purified neurotoxin, Type A)
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 25/100
25
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Glabellar Frown Lines
Conditions
Glabellar Frown Lines
Trial Timeline
May 1, 2015 → Nov 1, 2016
NCT ID
NCT02428608About DWP-450 (Botulinum purified neurotoxin, Type A)
DWP-450 (Botulinum purified neurotoxin, Type A) is a phase 2 stage product being developed by Evolus for Glabellar Frown Lines. The current trial status is completed. This product is registered under clinical trial identifier NCT02428608. Target conditions include Glabellar Frown Lines.
What happened to similar drugs?
0 of 11 similar drugs in Glabellar Frown Lines were approved
Approved (0) Terminated (0) Active (11)
Hype Score Breakdown
Clinical
12
Activity
8
Company
5
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02428608 | Phase 2 | Completed |
Competing Products
19 competing products in Glabellar Frown Lines
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| AGN-151586 + BOTOX + Placebo | AbbVie | Phase 1 | 29 |
| Placebo + AGN-151586 | AbbVie | Phase 3 | 40 |
| AGN-151586 + Placebo | AbbVie | Phase 3 | 40 |
| AGN-151586 + OnabotulinumtoxinA + Placebo | AbbVie | Phase 1 | 29 |
| AGN-151586 + Placebo | AbbVie | Phase 3 | 40 |
| AGN-151586 | AbbVie | Phase 3 | 40 |
| AGN-151586 + Placebo | AbbVie | Phase 1 | 29 |
| Botulinum toxin type A + Botulinum toxin type A + Placebo + Placebo | Ipsen | Phase 3 | 37 |
| IPN10200 + Placebo | Ipsen | Phase 3 | 44 |
| Botulinum toxin type A + Placebo | Ipsen | Phase 3 | 37 |
| Botulinum toxin type A + Botulinum toxin type A + Placebo | Ipsen | Phase 2 | 32 |
| Botulinum toxin type A + Placebo | Ipsen | Phase 3 | 37 |
| IPN10200 + Placebo | Ipsen | Phase 3 | 44 |
| prabotulinumtoxinA | Evolus | Pre-clinical | 20 |
| PrabotulinumtoxinA-Xvfs + OnabotulinumtoxinA + PrabotulinumtoxinA-Xvfs | Evolus | Phase 2 | 25 |
| Botulinum toxin, Type A | Evolus | Phase 3 | 30 |
| Botulinum toxin, Type A | Evolus | Phase 3 | 30 |
| Botulinum purified neurotoxin, Type A | Evolus | Phase 2 | 25 |
| prabotulinumtoxinA | Evolus | Phase 1 | 19 |